Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | C. Heissenberger et al., Nucleic Acids Res., 2019, 47, 22: 11807–11825, doi: 10.1093/nar/gkz1043 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene EASY | publication | M. De Luca et al., J. Cell Sci., Jun 2014; 127: 2697 - 2708 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene EASY | publication | M. De Luca et al., J. Cell Sci., Jun 2014; 127: 2697 - 2708 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | plasmid | stable transfection | Metafectene PRO | publication | R. Martınez-Marmol et al., Cell. Mol. Life Sci., 2016, 73:1515-1528; DOI 10.1007/s00018-015-2082-0 | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. T. Hellwig et al., J. Biol. Chem., Aug 2008; 283: 21676 - 21685 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. Fathinajafabadi et al., PLoS ONE, 2014, 9(2): e87898, doi:10.1371/journal.pone.0087898 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | Y. P. Abudu et al., J. Cell Biol., 2021, 220(8): e202009092, doi: 10.1083/jcb.202009092 | Link | |
HEp-2 |
Human carcinoma cell line (HeLa contaminant) | ATCC CCL-23 | Human | unknown | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J.-S. Kim et al., Cancer Biol. & Ther., 2012, 13: 1307–1318, doi.org/10.4161/cbt.21788 | Link | |
hLEC |
Human lens epithelial cell line | Human | sensory organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | Y. Su et al., Molecular Vision, 2012, 18: 601-605 | Link | ||
hRPEC |
Human retinal pigment epithelial cells | Human | sensory organs | primary cell | adherent | siRNA | stable transfection | Metafectene | publication | I-Ta Lee et al., PLoS ONE 10(2): e0117911. doi:10.1371/journal.pone.0117911 | Link | ||
hVSMC |
Human primary vascular smooth muscle cells | Human | vasculature | primary cell | adherent | plasmid | stable transfection | Metafectene | publication | G. Weisinger et al., Exp. Cell Res., 2013, 319: 1586-1593, doi.org/10.1016/j.yexcr.2013.04.001 | |||
iPSCs |
Mouse induced pluripotent stem cells | Mouse | unknown | stem cell | adherent | plasmid | stable transfection | Metafectene | publication | J. Kuehle et al., Mol. Therapy, 2014, 22(5) :919-928, doi:10.1038/mt.2014.4 | Link | ||
L cells |
Mouse subcutaneous connective tissue fibroblast cell line | ATCC CRL-2648 | Mouse | other | cell line | adherent | plasmid | stable transfection | Metafectene | publication | V. J. Jokubaitis et al., Blood, Apr 2008; 111: 4055 - 4063 | Link | |
Lec1 |
Chinese hamster ovary cell line | ATCC CRL-1735 | Hamster | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A. Altamirano et al., J. Proteome Res., 2018, 17: 1269−1277, DOI:10.1021/acs.jproteome.7b00867 | ||
LLC-PK1 |
Swine kidney ephitelial cell line | ATCC CL-101 | Swine | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | application note | ![]() |
||
LM16-R |
Human melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Eriomina, thesis, 2020, The Open University, doi.org/10.21954/ou.ro.00011212 | Link | ||
LM16-S |
Human melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Eriomina, thesis, 2020, The Open University, doi.org/10.21954/ou.ro.00011212 | Link | ||
LN-18 |
Human brain glioblastoma cell line | ATCC CRL-2610 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | F. Weipert, Dissertation, 2018, Technische Universiät Darmstadt | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | C. Wanka et al., J. Biol. Chem., Sep 2012; 287: 33436 - 33446 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | W. C. Brucker et al., Zurich Open Repository and Archive, University of Zurich, 2012, doi.org/10.1038/onc.2011.530 | Link | |
LN-229 |
Human brain glioblastoma cell line | ATCC CRL-2611 | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Happold et al., Mol. Cancer Ther., Apr 2014; 13: 948 - 961 | Link | |
LN-308 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | G. Eisele et al., Neuro Oncology, Feb 2011; 13: 155 - 164 | Link | ||
M1 |
Mouse epithelial M1 cells | Mouse | unknown | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. O. Nørgård et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.07.05.451120 | Link |